SEC Filing Summary for Edward J. Rapp - AbbVie Inc.

This SEC filing details a transaction by Edward J. Rapp, a director at AbbVie Inc. (ABBV), on May 8, 2026. Rapp acquired 1118 shares of Common Stock with a par value of $0.01 through restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program. These units are set to be paid in shares of AbbVie common stock on the earlier of the director's separation from service, death, or a change in control. The transaction code is "A" for acquisition, with a price per share of $0.0. Following this transaction, Rapp holds 45,964 shares. The filing also notes that total holdings include 10,388 shares previously held indirectly by a spouse, now held directly. The signature date on the filing is May 12, 2026.